Literature DB >> 17901225

Cellular and subcellular evidence for neuronal interaction between the chemokine stromal cell-derived factor-1/CXCL 12 and vasopressin: regulation in the hypothalamo-neurohypophysial system of the Brattleboro rats.

Céline Callewaere1, Brigitte Fernette, Danièle Raison, Patricia Mechighel, Arlette Burlet, André Calas, Patrick Kitabgi, Stéphane Mélik Parsadaniantz, William Rostène.   

Abstract

We previously described a colocalization between arginine vasopressin (AVP) and the chemokine stromal cell-derived factor-1alpha (SDF-1) in the magnocellular neurons of both the hypothalamic supraoptic and paraventricular nucleus as well as the posterior pituitary. SDF-1 physiologically affects the electrophysiological properties of AVP neurons and consequently AVP release. In the present study, we confirm by confocal and electron microscopy that AVP and SDF-1 have a similar cellular distribution inside the neuronal cell and can be found in dense core vesicles in the nerve terminals in the posterior pituitary. Because the Brattleboro rats represent a good model of AVP deficiency, we tested in these animals the fate of SDF-1 and its receptor CXCR4. We identified by immunohistochemistry that both SDF-1 and CXCR4 immunoreactivity were strongly decreased in Brattleboro rats and were strictly correlated with the expression of AVP protein in supraoptic nucleus, paraventricular nucleus, and the posterior pituitary. We observed by real-time PCR an increase in SDF-1 mRNA in both heterozygous and homozygous rats. The effect on the SDF-1/CXCR4 system was not linked to peripheral modifications of kidney water balance because it could not be restored by chronic infusion of deamino-8D-ariginine-vasopressin, an AVP V2-receptor agonist. These original data further suggest that SDF-1 may play an essential role in the regulation of water balance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17901225      PMCID: PMC2194606          DOI: 10.1210/en.2007-1097

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  43 in total

Review 1.  Mutant vasopressin precursor producing cells of the homozygous Brattleboro rat as a model for co-expression of neuropeptides.

Authors:  F W van Leeuwen
Journal:  Prog Brain Res       Date:  1992       Impact factor: 2.453

2.  Cytokine-induced neutrophil chemoattractant gene expression in the rat hypothalamus by osmotic stimulation.

Authors:  K Koike; Y Sakamoto; H Kiyama; K Masuhara; A Miyake; M Inoue
Journal:  Brain Res Mol Brain Res       Date:  1997-12-15

3.  Stability of the vasopressin V2 receptor-adenylyl cyclase system in rat kidney.

Authors:  T Shen; J Laycock; Y Suzuki; N Defer; J Hanoune
Journal:  Eur J Pharmacol       Date:  1998-01-02       Impact factor: 4.432

4.  Ingestive behaviors of the rat deficient in vasopressin synthesis (Brattleboro strain). Effect of chronic treatment by dDAVP.

Authors:  A Burlet; D Desor; J P Max; J P Nicolas; B Krafft; C Burlet
Journal:  Physiol Behav       Date:  1990-12

5.  Induction of V2 receptors in renal medulla of homozygous Brattleboro rats by arginine vasopressin.

Authors:  L E Cornett; S M Breckinridge; T I Koike
Journal:  Peptides       Date:  1989 Sep-Oct       Impact factor: 3.750

6.  Short-term effects of centrally administered galanin on the hyperosmotically stimulated expression of vasopressin in the rat hypothalamus. An in situ hybridization and immunohistochemistry study.

Authors:  M Landry; D Roche; A Calas
Journal:  Neuroendocrinology       Date:  1995-04       Impact factor: 4.914

7.  Reversal of diabetes insipidus in Brattleboro rats: intrahypothalamic injection of vasopressin mRNA.

Authors:  G F Jirikowski; P P Sanna; D Maciejewski-Lenoir; F E Bloom
Journal:  Science       Date:  1992-02-21       Impact factor: 47.728

Review 8.  Vasopressin and oxytocin receptors in the central nervous system.

Authors:  C Barberis; E Tribollet
Journal:  Crit Rev Neurobiol       Date:  1996

9.  Long-term gene therapy in the CNS: reversal of hypothalamic diabetes insipidus in the Brattleboro rat by using an adenovirus expressing arginine vasopressin.

Authors:  B J Geddes; T C Harding; S L Lightman; J B Uney
Journal:  Nat Med       Date:  1997-12       Impact factor: 53.440

10.  Microvesicles of the neurohypophysis are biochemically related to small synaptic vesicles of presynaptic nerve terminals.

Authors:  F Navone; G Di Gioia; R Jahn; M Browning; P Greengard; P De Camilli
Journal:  J Cell Biol       Date:  1989-12       Impact factor: 10.539

View more
  6 in total

1.  Implication of CCR2 chemokine receptor in cocaine-induced sensitization.

Authors:  Jean Marc Trocello; William Rostene; Stephane Melik-Parsadaniantz; David Godefroy; Emmanuel Roze; Patrick Kitabgi; William A Kuziel; Sylvie Chalon; Jocelyne Caboche; Emmanuelle Apartis
Journal:  J Mol Neurosci       Date:  2011-03-22       Impact factor: 3.444

Review 2.  When human immunodeficiency virus meets chemokines and microglia: neuroprotection or neurodegeneration?

Authors:  Italo Mocchetti; Lee A Campbell; G Jean Harry; Valeriya Avdoshina
Journal:  J Neuroimmune Pharmacol       Date:  2012-04-15       Impact factor: 4.147

3.  SDF-1alpha/CXCL12 enhances GABA and glutamate synaptic activity at serotonin neurons in the rat dorsal raphe nucleus.

Authors:  Silke Heinisch; Lynn G Kirby
Journal:  Neuropharmacology       Date:  2009-09-13       Impact factor: 5.250

Review 4.  Neuroprotective effects of physical activity on the brain: a closer look at trophic factor signaling.

Authors:  Cristy Phillips; Mehmet Akif Baktir; Malathi Srivatsan; Ahmad Salehi
Journal:  Front Cell Neurosci       Date:  2014-06-20       Impact factor: 5.505

Review 5.  Emerging Targets in Pituitary Adenomas: Role of the CXCL12/CXCR4-R7 System.

Authors:  Federica Barbieri; Stefano Thellung; Roberto Würth; Federico Gatto; Alessandro Corsaro; Valentina Villa; Mario Nizzari; Manuela Albertelli; Diego Ferone; Tullio Florio
Journal:  Int J Endocrinol       Date:  2014-11-17       Impact factor: 3.257

Review 6.  Neuroprotective Effects of Exercise Treatments After Injury: The Dual Role of Neurotrophic Factors.

Authors:  Stefano Cobianchi; Ariadna Arbat-Plana; Víctor M Lopez-Alvarez; Xavier Navarro
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.